Software Products and Services:
07/2011-Present Bristol-Myers Squibb (BioPharma.) Medarex acquired by BMS for $2.4B.
03/2010-07/2011 Crescendo Bioscience (BioTech.) Acquired by Myriad Genetics (MYGN) for $270M.
10/2008-03/2010 Zenprise (Mobile Management.) Acquired by Citrix (CTSX) for $355M.
09/2007-10/2008 Clarity Medical Systems (Medical Device.)
We’ve updated our privacy policy so that we are compliant with changing global privacy regulations and to provide you with insight into the limited ways in which we use your data.
You can read the details below. By accepting, you agree to the updated privacy policy.